Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
54.79
+0.33 (0.61%)
Oct 22, 2024, 4:00 PM EDT - Market closed
Ultragenyx Pharmaceutical Employees
Ultragenyx Pharmaceutical had 1,276 employees as of December 31, 2023. The number of employees decreased by 35 or -2.67% compared to the previous year.
Employees
1,276
Change (1Y)
-35
Growth (1Y)
-2.67%
Revenue / Employee
$377,197
Profits / Employee
-$458,559
Market Cap
5.05B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Acadia Healthcare Company | 23,500 |
DENTSPLY SIRONA | 15,000 |
RadNet | 8,441 |
Option Care Health | 7,802 |
Stevanato Group | 5,634 |
BridgeBio Pharma | 556 |
Corcept Therapeutics | 352 |
Biohaven | 239 |
RARE News
- 4 days ago - Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 19 days ago - Ultragenyx Provides Update on Stage 1 Cohorts in Pivotal Phase 1/2/3 Cyprus2+ Study Evaluating UX701 Gene Therapy for the Treatment of Wilson Disease - GlobeNewsWire
- 26 days ago - Ultragenyx Announces Upcoming Setrusumab (UX143) Presentations at the ASBMR 2024 Annual Meeting - GlobeNewsWire
- 7 weeks ago - Ultragenyx to Participate in Investor Conferences in September - GlobeNewsWire
- 2 months ago - Ultragenyx's Strong Pipeline And Valuation Concerns: A Balanced Perspective - Seeking Alpha
- 2 months ago - Ultragenyx Pharmaceutical Inc. (RARE) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Amlogenyx Inc. Closes Successful Seed Funding Led by GordonMD® Global Investments LP - Business Wire
- 2 months ago - Ultragenyx Reports Second Quarter 2024 Financial Results and Corporate Update - GlobeNewsWire